OncoSec Medical (FRA:ONMA) COGS-to-Revenue : 0.00 (As of Jan. 2023)

View and export this data going back to 2015. Start your Free Trial

What is OncoSec Medical COGS-to-Revenue?

OncoSec Medical's Cost of Goods Sold for the three months ended in Jan. 2023 was €0.00 Mil. Its Revenue for the three months ended in Jan. 2023 was €0.00 Mil.

OncoSec Medical's COGS to Revenue for the three months ended in Jan. 2023 was 0.00.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. OncoSec Medical's Gross Margin % for the three months ended in Jan. 2023 was N/A%.

OncoSec Medical COGS-to-Revenue Historical Data

The historical data trend for OncoSec Medical's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

OncoSec Medical COGS-to-Revenue Chart

OncoSec Medical Annual Data

Trend

Jul13

Jul14

Jul15

Jul16

Jul17

Jul18

Jul19

Jul20

Jul21

Jul22

COGS-to-Revenue

Get a 7-Day Free Trial

OncoSec Medical Quarterly Data
	Apr18	Jul18	Oct18	Jan19	Apr19	Jul19	Oct19	Jan20	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23
COGS-to-Revenue	Get a 7-Day Free Trial															-	-	-	-	-

OncoSec Medical COGS-to-Revenue Calculation

OncoSec Medical's COGS to Revenue for the fiscal year that ended in Jul. 2022 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	0	/	0
	=

OncoSec Medical's COGS to Revenue for the quarter that ended in Jan. 2023 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	0	/	0
	=

OncoSec Medical (FRA:ONMA) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

OncoSec Medical's Gross Margin % for the three months ended in Jan. 2023 is calculated as:

Gross Margin %	=	1	-	COGS to Revenue
	=	1	-	Cost of Goods Sold / Revenue
	=	1	-	0 / 0
	=	N/A %

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

OncoSec Medical COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of OncoSec Medical's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

OncoSec Medical (FRA:ONMA) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » OncoSec Medical Inc (FRA:ONMA) » Definitions » COGS-to-Revenue

Comparable Companies

Traded in Other Exchanges

ONCSQ:USA

Address

24 North Main Street, Pennington, NJ, USA, 08534

Website

https://www.oncosec.com

OncoSec Medical Inc is a healthcare sector company. It is focused on designing, developing and commercializing gene therapies, therapeutics, and medical approaches to stimulate an anti-tumor immune response for the treatment of cancer. The company's lead product candidate, ImmunoPulse IL-12, consists of a plasmid construct encoding the proinflammatory cytokine, IL-12, which is delivered into the tumor through in vivo electroporation. In addition, it is pursuing ImmunoPulse IL-12 monotherapy in patients with triple-negative breast cancer.

OncoSec Medical (FRA:ONMA) Headlines

No Headlines